Philadelphia University + Thomas Jefferson University

Cerebrovascular Trials

Active Studies

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter, Phase 3 Pivotal Study to Assess the Safety and Efficacy 01mg/kg/day Intravenous DP-b99 Over 4 Consecutive Days versus Placebo when Initiated Within Nine Hours of Acute Ischemic Stroke Onset.

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects with Acute Ischemia Stroke.

Insulin Resistance Intervention After Stroke (IRIS) trial